Open Insider Trading Activity for Molecular Insight Pharmaceuticals, Inc. Sr. VP Clinical Dev and CMO Lafrance Norman D.
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting MIPI | 2009-05-29 | 2009-05-28 | Molecular Insight Pharmaceuticals, Inc. | Lafrance Norman D. | Sr. VP Clinical Dev and CMO | Sell | 1 | 6,093 | $3.76 | $22,909.68 | 26.78% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. MIPI | 2007-12-04 | 2007-11-30 | Molecular Insight Pharmaceuticals, Inc. | Lafrance Norman D. | Sr. VP Clinical Dev and CMO | Buy | 2 | 2,000 | $8.78 | $17,557.00 | 32.79% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. MIPI | 2007-11-30 | 2007-11-29 | Molecular Insight Pharmaceuticals, Inc. | Lafrance Norman D. | Sr. VP Clinical Dev and CMO | Buy | 2 | 2,000 | $8.05 | $16,090.00 | 95.24% | View Filing |